"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Technical report
peer-reviewed

You Can Do That? Performing Total Recanalization of Completely Stented Arterial-venous Grafts



Abstract

Establishing venous access in chronic dialysis patients is conducted by the insertion of polytetrafluoroethylene arterial-venous (AV) grafts. The continual access of these grafts allows for potential failure over extended periods of hemodialysis treatment, as a result of thrombosis and pseudoaneurysm formation. Patency of AV grafts requires interventional management of thrombosis and pseudoaneurysm formation, including thrombectomy and covered stent placement, respectively. In 2013, the Food and Drug Administration approved the Gore REVISE study, giving indication for covered stents within AV grafts. If covered stent placement is required to treat a thrombosed AV graft, it is still possible to perform a percutaneous thrombectomy procedure afterwards. Direct access of the AV graft by passing through both the graft material and covered stents allows for interventional radiology management to be performed without compromise of the stent or graft. This interventional method of direct access can salvage the AV graft before considering further invasive management, such as a new surgical venous access site.

Introduction

Maintaining venous access in chronic hemodialysis (HD) patients can be very challenging. Various methods such as trans-lumbar inferior vena cava access, dual-lumen central venous catheter placement, and extremity surgical graft placement have all been implemented to acquire adequate venous access in HD patients. In the case of arterial-venous (AV) grafts, complications such as thrombosis within the graft are well-documented in the literature [1]. An interventional percutaneous thrombectomy involves directly accessing the graft lumen by puncturing the graft material in an antegrade and retrograde fashion. Subsequently, mechanical thrombectomy, angioplasty, embolectomy and covered stent placement can be performed. This form of interventional management is an appropriate approach for treating thrombosed HD grafts [2].

Once a current AV graft has become significantly thrombosed and dysfunctional, it is readily acceptable to attempt covered stenting or thrombolysis to maintain graft patency [3]. We propose another method in addition to these under the circumstance that an AV graft has been completely repaired with multiple covered stents. This option warrants necessity when attempting to save a thrombosed stent-lined AV graft in chronically dialyzed patients.

Technical Report

For the aforementioned percutaneous declot of an AV graft that is covered stent lined, a 51-year-old African American male with a past medical history of hypertension and end stage renal disease (ESRD) requiring permanent dialysis is presented. For hemodialysis access, the patient required a polytetrafluoroethylene AV graft that was placed in his left upper extremity. The patient received dialysis through the AV graft without incident until six months later, when the graft was found to have pseudoaneurysms (Figure 1).

The graft wall was accessed with a micropuncture kit. At this time, it was determined that two Viabahn (W.L. Gore & Associates, Flagstaff, AZ) covered stents were necessary to exclude the pseudoaneurysms (Figure 2).

Six months later, the patient returned and reported AV graft malfunction. Due to the patient’s medical history, age, and graft condition, it was decided to attempt direct percutaneous access of the graft, though it was lined with multiple covered stents instead of abandoning the graft (Figure 3).

Initially using a cross-catheter technique for the declot procedure, the patient’s AV graft was accessed with 19-gauge needles at the proximal and distal aspects of the venous limb, through the existing covered stents aligning the venous outflow. Hand injection venogram at the distal venous outflow revealed thrombus formation (Figure 4).

A Bentson guidewire was advanced antegrade across the venous anastomosis site, and a seven French sheath was placed. An angled tip Glidewire (Terumo, Somerset, NJ) was advanced retrograde across the arterial anastomosis site, and a Fogarty balloon catheter was advanced over the wire into the distal brachial artery. Pre-angioplasty of the venous anastomotic site was performed using a 6 mm by 40 mm balloon. The angioplasty catheter was then exchanged for an AngioJet thrombectomy catheter (Boston Scientific, Marlborough, MA), which was used to remove the extensive thrombosis from the venous limb of the graft. The Fogarty balloon catheter was then deployed at the arterial anastomosis, and used to retrieve clot from the arterial limb into the venous limb for AngioJet removal (Figure 5).

The arterial anastomosis also demonstrated high-grade stenosis, decreasing blood flow and prompting angioplasty (Figure 6).

A 5 mm cutting balloon was utilized within the anastomosis (Figure 7).

Follow-up angiogram from the brachial artery to evaluate the arterial anastomosis showed excellent results with no residual stenosis (Figure 8).

Discussion

Thrombosis of AV grafts is the most frequently encountered complication for patients receiving chronic hemodialysis, occurring in one-fourth to two-thirds of this patient population [4]. AV grafts remain patent for an average of 10 months before significant thrombosis occurs, and either surgical or interventional management must be considered [5]. For those with ESRD, HD access is the leading cause for hospitalization [6]. For these reasons as well as the increasing number of patients on chronic dialysis, it is important to continue exploring new interventional methods for preservation of AV grafts.

Historically, patients have managed to salvage the function of their stented AV grafts by receiving various methods of declot intervention, including the majority of our patients at our institution [7]. Following thrombectomy, AV grafts have been shown to remain patent for three months in 55.9% of patients following initial intervention, in 61.9% of patients following a second intervention, and in 55.8% of patients following a third intervention [8]. This data suggests that percutaneous management of significantly thrombosed AV grafts should be implemented, in order to prolong the function of these grafts for as long as possible [8]. Furthermore, this infers that attempting interventional declot by percutaneously accessing the AV graft directly is a viable option to perform. After all, these covered stent-lined grafts are continually accessed multiple times a week for HD. The physical repeated access of AV grafts for HD has not shown to cause complications in function [9].

The alternative to the proposed percutaneous declot procedure of covered stents in existing AV grafts is to access a new HD site by catheter placement or de novo creation. It is not uncommon that access options are limited despite the necessity for hemodialysis once a native AV has been significantly or completely thrombosed. Patients will often receive imperative but risky procedures that include surgical establishment of new AV grafts, in order to acquire the venous access that is needed for further hemodialysis [10]. Additionally, these surgical procedures may require burdensome hospital stays, where the increased risk for infection in these patients who are already immunocompromised, increases [11]. Understanding the indispensable value for maintaining a patent site for HD access is paramount in chronically dialyzed patients. The proposed method for percutaneous interventional management of covered stented AV graft maintenance, applied under the appropriate circumstances, is a novel and advantageously therapeutic intervention. As presented, this interventional method is shown to be less invasive over the traditional surgical establishment of new venous access sites in patients requiring continual hemodialysis.

Possible candidates for the proposed intervention presented here include any patient with a graft lined by covered stents. It has been explained that primary and secondary declotting of grafts is preferred over the creation of a new venous access site. Therefore, it is suggested that the direct percutaneous access of a covered stent-lined graft for thrombectomy should be considered. In an extensive literature search, specific examples of the intervention presented here could not be found, but it is suspected that interventions as such have been attempted successfully.

Conclusions

The most common complication in chronically hemodialyzed patients is AV graft malfunction, as a result of significant or complete thrombosis. With the recent Food and Drug Administration approval of the Gore REVISE clinical study for covered stents within AV grafts, the number of reinterventions will increase. With this approval, the described techniques presented in this article will be routine in the future. Traditional methods to maintain hemodialysis access include risky and invasive management, such as surgical establishment of new venous access sites. Surgical intervention as such leads to prolonged hospital stays, increased risk for infection, and other unnecessary or inconvenient complications. To eliminate the risk of superfluous management in chronic hemodialysis patients, interventional percutaneous thrombectomy of multiple-lined cover stented AV grafts should be performed in order to salvage the function of the graft. Furthermore, this may prevent the necessity for establishing new venous access sites, and avoiding additional invasive surgical procedures altogether.


References

  1. Quencer KB, Oklu R: Hemodialysis access thrombosis. Cardiovasc Diagn Ther. 2017, 7: S299-S308. 10.21037/cdt.2017.09.08
  2. Miller GA, Preddie DC, Savransky Y, Spergel LM: Use of the Viabahn stent graft for the treatment of recurrent cephalic arch stenosis in hemodialysis accesses. J Vasc Surg. 2018, 67:522-528. 10.1016/j.jvs.2017.08.018
  3. Quaretti P, Leati G, Moramarco LP, et al.: Percutaneous transanastomotic stent graft deployment to salvage dysfunctional native forearm radiocephalic fistulae: feasibility and primary patency at 12 months. J Vasc Interv Radiol. 2018, 29:986-992. 10.1016/j.jvir.2018.02.028
  4. Schild AF, Perez E, Gillaspie E, Seaver C, Livingstone J, Thibonnier A: Arteriovenous fistulae vs. arteriovenous grafts: a retrospective review of 1,700 consecutive vascular access cases. J Vasc Access. 2018, 9:231-235. 10.1177/112972980800900402
  5. Raju S: PTFE grafts for hemodialysis access. Techniques for insertion and management of complications. Ann Surg. 1987, 206:666-673.
  6. Arora P, Kausz AT, Obrador GT, et al.: Hospital utilization among chronic dialysis patients. J Am Soc Nephrol. 2000, 11:740-746.
  7. Kitrou PM, Papadimatos P, Spiliopoulos S, Christeas N, Katsanos K, Karnabatidis D: Lysis-assisted balloon (LAB) thrombectomy. A declotting technique for the treatment of thrombosed arteriovenous dialysis grafts. 5-year experience of 241 endovascular procedures. Cardiovasc Intervent Radiol. 2018, 41:245-252. 10.1007/s00270-017-1813-z
  8. Mansilla AV, Toombs BD, Vaughn WK, Zeledon JI: Patency and life-spans of failing hemodialysis grafts in patients undergoing repeated percutaneous de-clotting. Tex Heart Inst J. 2001, 28:249-253.
  9. Rayner HC, Pisoni RL, Gillespie BW, et al.: Creation, cannulation and survival of arteriovenous fistulae: data from the dialysis outcomes and practice patterns study. Kidney Int. 2003, 63:323-330. 10.1046/j.1523-1755.2003.00724.x
  10. Kim D, Bhola C, Eisenberg N, Montbriand J, Oreopoulos G, Lok CE, Roche-Nagle G: Long-term results of thigh arteriovenous dialysis grafts. J Vasc Access. 2018, 10.1177/1129729818787994
  11. Malik J: Heart disease in chronic kidney disease - review of the mechanisms and the role of dialysis access. J Vasc Access. 2018, 19:3-11. 10.5301/jva.5000815
Technical report
peer-reviewed

You Can Do That? Performing Total Recanalization of Completely Stented Arterial-venous Grafts


Author Information

Taylor S. Harmon Corresponding Author

Interventional Radiology, The University of Texas Medical Branch, Galveston, USA

Travis E. Meyer

Interventional Radiology, University of Florida College of Medicine, Jacksonville, USA

Jerry Matteo

Interventional Radiology, University of Florida College of Medicine, Jacksonville, USA


Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.


Technical report
peer-reviewed

You Can Do That? Performing Total Recanalization of Completely Stented Arterial-venous Grafts


Figures etc.

PDF Share